S
SNDX
Syndax Pharmaceuticals Inc
19.59
-0.16-0.81%After Hours: 19.90 +0.31 +1.59%18:17 05/29 EDT
OPEN/PREV CLOSE19.75/19.75
TODAY RANGE19.43-19.88
VOL862.05K
MARKET CAP1.74B
52 WEEK RANGE8.59-25.59
AVG VOL (3M)1.55M
% TURNOVER0.97%
TURNOVER--
P/E (TTM)-6.9984
% RANGE2.28%
EPS(TTM)-2.7992
P/E(FORWARD)-10.7049
P/B41.67
BVPS0.4701
DIVIDEND--
P/S9.93
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.68B
SHARES OUTSTANDING88.61M
NEXT EARNINGS08/03-08/07
FREE FLOAT85.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·5d ago
Did New Revuforj Post‑Transplant Data at ASCO 2026 Just Shift Syndax Pharmaceuticals' (SNDX) Investment Narrative?
Simply Wall St·05/21 14:31
Assessing Syndax Pharmaceuticals (SNDX) Valuation After New Revuforj Leukemia Data Spurs Investor Interest
Simply Wall St·05/14 13:42
Does Expanded Revuforj Leukemia Data Set Change The Bull Case For Syndax Pharmaceuticals (SNDX)?
Dow Jones·05/13 15:06
Syndax Pharmaceuticals Is Maintained at Buy by UBS
Dow Jones·05/13 15:06
Syndax Pharmaceuticals Price Target Cut to $37.00/Share From $38.00 by UBS
Benzinga·05/13 14:56
UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $37
Reuters·05/13 13:49
SYNDAX PHARMACEUTICALS INC <SNDX.O>: UBS CUTS TARGET PRICE TO $37 FROM $38